BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24862148)

  • 1. Thrombocytopenia in cancer patients.
    Liebman HA
    Thromb Res; 2014 May; 133 Suppl 2():S63-9. PubMed ID: 24862148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.
    Gordon LI; Kwaan HC
    Semin Thromb Hemost; 1999; 25(2):217-21. PubMed ID: 10357089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.
    Kuter DJ
    Haematologica; 2022 Jun; 107(6):1243-1263. PubMed ID: 35642485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Approaches to anemia, thrombocytopenia, and DIC in cancer patients].
    Matsushita T
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):6-12. PubMed ID: 16410690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding problems in the cancer patient.
    Rosen PJ
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1315-28. PubMed ID: 1452514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose reductions and delays: limitations of myelosuppressive chemotherapy.
    Cairo MS
    Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):21-31. PubMed ID: 11033835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia.
    Gauer RL; Braun MM
    Am Fam Physician; 2012 Mar; 85(6):612-22. PubMed ID: 22534274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
    James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
    Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.
    George JN
    Oncology (Williston Park); 2011 Sep; 25(10):908-14. PubMed ID: 22010388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emergency blood picture].
    Tobler A
    Schweiz Med Wochenschr; 1993 Apr; 123(15):711-20. PubMed ID: 8488374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expert consensus on rational use of recombinant human IL-11 for thrombocytopenia in solid tumor patients].
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):948-9. PubMed ID: 21223808
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes.
    Bhatia M; Davenport V; Cairo MS
    Leuk Lymphoma; 2007 Jan; 48(1):9-15. PubMed ID: 17325843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic manifestations of malignancy.
    Johnson RA; Roodman GD
    Dis Mon; 1989 Nov; 35(11):721-68. PubMed ID: 2680358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
    Wu Y; Aravind S; Ranganathan G; Martin A; Nalysnyk L
    Clin Ther; 2009; 31 Pt 2():2416-32. PubMed ID: 20110050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
    Bates JS; Buie LW; Woodis CB
    Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet support and the use of cytokines.
    Bishop JF
    Stem Cells; 1994 Jul; 12(4):370-7. PubMed ID: 7524892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.